Study Details

Back
Study ID 2215-CL-0105
Study Title A Phase 1 Open-label Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients with Advanced Solid Tumors
Clinicaltrials.gov Identifier NCT02456883
Compound Name ASP2215 / gilteritinib fumarate
Medical Indication or Disease Solid tumors
Study Sponsor Astellas Pharma Global Development Inc.
Collaborator Not Applicable
Study Start Date 04-Mar-2016
Study Completion Date 19-Jun-2017
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS